These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38511291)

  • 1. Selective Potentiation of the (α4)
    Appiani R; Viscarra F; Biggin PC; Bermudez I; Giraudo A; Pallavicini M; Bolchi C
    ACS Chem Neurosci; 2024 Apr; 15(7):1501-1514. PubMed ID: 38511291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
    Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
    Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.
    Grupe M; Jensen AA; Ahring PK; Christensen JK; Grunnet M
    Br J Pharmacol; 2013 Apr; 168(8):2000-10. PubMed ID: 23278456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
    Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
    J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
    Mazzaferro S; Bermudez I; Sine SM
    Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand Binding at the 4-4 Agonist-Binding Site of the 42 nAChR Triggers Receptor Activation through a Pre-Activated Conformational State.
    Indurthi DC; Lewis TM; Ahring PK; Balle T; Chebib M; Absalom NL
    PLoS One; 2016; 11(8):e0161154. PubMed ID: 27552221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
    Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
    J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
    Jain A; Kuryatov A; Wang J; Kamenecka TM; Lindstrom J
    J Biol Chem; 2016 Nov; 291(45):23452-23463. PubMed ID: 27645992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting activity of (α4)
    Wang J; Blasio A; Chapman HL; Doebelin C; Liaw V; Kuryatov A; Giovanetti SM; Lindstrom J; Lin L; Cameron MD; Kamenecka TM; Pomrenze MB; Messing RO
    Neuropsychopharmacology; 2020 Jan; 45(2):301-308. PubMed ID: 31394567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
    Wang J; Lindstrom J
    Br J Pharmacol; 2018 Jun; 175(11):1805-1821. PubMed ID: 28199738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
    Moroni M; Vijayan R; Carbone A; Zwart R; Biggin PC; Bermudez I
    J Neurosci; 2008 Jul; 28(27):6884-94. PubMed ID: 18596163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC.
    Norleans J; Wang J; Kuryatov A; Leffler A; Doebelin C; Kamenecka TM; Lindstrom J
    J Biol Chem; 2019 Aug; 294(32):12132-12145. PubMed ID: 31221718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI.
    Deba F; Munoz K; Peredia E; Akk G; Hamouda AK
    J Biol Chem; 2022 Jan; 298(1):101455. PubMed ID: 34861241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
    Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
    PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stoichiometry-Selective Antagonism of α4β2 Nicotinic Acetylcholine Receptors by Fluoroquinolone Antibiotics.
    Sanders VR; Sweeney A; Topf M; Millar NS
    ACS Chem Neurosci; 2022 Jun; 13(12):1805-1817. PubMed ID: 35657695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.